Literature DB >> 23960579

Optimizing door-to-balloon times for STEMI interventions - Results from the SINCERE database.

Sameer Mehta1, Estefanía Oliveros, Carlos E Alfonso, Esther Falcão, Faisal Shamshad, Ana I Flores, Salomon Cohen.   

Abstract

BACKGROUND: Primary angioplasty decreases mortality and improves long-term outcomes for patients with STEMI. To be most effective, it needs to be performed expediently, with door-to-balloon times (D2B) less than 90 min.
METHODS: From January 2005 to presently, 420 short D2B STEMI interventions were performed at 5 community hospitals by a single experienced operator creating the SINCERE (Single INdividual Community Experience REgistry) database.
RESULTS: Median D2B time was 78 min, median procedure time (local anesthesia to recanalization) was 13 min; 85.2% of procedures had D2B time <90 min; 95% of the procedures were successful - relief of chest pain, >70% ST segment resolution, TIMI 3 flow and Myocardial Perfusion Grade 3.
CONCLUSIONS: Primary PCI with high success rates and predictable short D2B times can be performed with standardized techniques in community hospitals.

Entities:  

Keywords:  Door-to-balloon times; Primary PCI; STEMI

Year:  2009        PMID: 23960579      PMCID: PMC3727368          DOI: 10.1016/j.jsha.2009.10.006

Source DB:  PubMed          Journal:  J Saudi Heart Assoc        ISSN: 1016-7315


  53 in total

1.  Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol.

Authors:  Henry H Ting; Charanjit S Rihal; Bernard J Gersh; Luis H Haro; Christine M Bjerke; Ryan J Lennon; Choon-Chern Lim; John F Bresnahan; Allan S Jaffe; David R Holmes; Malcolm R Bell
Journal:  Circulation       Date:  2007-08-01       Impact factor: 29.690

2.  A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1997-06-05       Impact factor: 91.245

3.  Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial. Rapid Early Action for Coronary Treatment (REACT) Study Group.

Authors:  D C Goff; H A Feldman; P G McGovern; R J Goldberg; D G Simons-Morton; C E Cornell; S K Osganian; L S Cooper; J R Hedges
Journal:  Am Heart J       Date:  1999-12       Impact factor: 4.749

4.  Achieving door-to-balloon times that meet quality guidelines: how do successful hospitals do it?

Authors:  Elizabeth H Bradley; Sarah A Roumanis; Martha J Radford; Tashonna R Webster; Robert L McNamara; Jennifer A Mattera; Barbara A Barton; David N Berg; Edward L Portnay; Harry Moscovitz; Janet Parkosewich; Eric S Holmboe; Martha Blaney; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2005-10-04       Impact factor: 24.094

5.  Demographic, belief, and situational factors influencing the decision to utilize emergency medical services among chest pain patients. Rapid Early Action for Coronary Treatment (REACT) study.

Authors:  A L Brown; N C Mann; M Daya; R Goldberg; H Meischke; J Taylor; K Smith; S Osganian; L Cooper
Journal:  Circulation       Date:  2000-07-11       Impact factor: 29.690

6.  Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3.

Authors:  W J Rogers; J G Canto; C T Lambrew; A J Tiefenbrunn; B Kinkaid; D A Shoultz; P D Frederick; N Every
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

7.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-31       Impact factor: 29.690

8.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.

Authors:  R J Gibbons; D R Holmes; G S Reeder; K R Bailey; M R Hopfenspirger; B J Gersh
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time.

Authors:  Jean-Michel Juliard; Laurent J Feldman; Jean-Louis Golmard; Dominique Himbert; Hakim Benamer; Tinouche Haghighat; Daniel Karila-Cohen; Pierre Aubry; Alec Vahanian; Ph Gabriel Steg
Journal:  Am J Cardiol       Date:  2003-06-15       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.